4.7 Article

Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Systemic sclerosis

Christopher P. Denton et al.

LANCET (2017)

Article Rheumatology

Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma

Ami A. Shah et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Review Immunology

Novel risk factors related to cancer in scleroderma

David Bernal-Bello et al.

AUTOIMMUNITY REVIEWS (2017)

Article Medicine, General & Internal

Advances in pathogenesis and treatment of systemic sclerosis

Christopher P. Denton

CLINICAL MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

Nazzareno Galiè et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2016)

Review Rheumatology

Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody

Alfredo Guillen-Del Castillo et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)

Article Rheumatology

Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis

Svetlana I. Nihtyanova et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Article Medicine, General & Internal

Systemic Sclerosis Establishing Diagnostic Criteria

Marie Hudson et al.

MEDICINE (2010)

Article Rheumatology

Anti-U11/U12 RNP Antibodies in Systemic Sclerosis: A New Serologic Marker Associated With Pulmonary Fibrosis

Noreen Fertig et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)

Review Rheumatology

Update on autoantibodies in systemic sclerosis

Jennifer G. Walker et al.

CURRENT OPINION IN RHEUMATOLOGY (2007)

Review Rheumatology

Autoantibodies in systemic sclerosis

VD Steen

SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)